Orano Med seeks to develop a new generation of targeted therapies against cancer using the unique properties of lead-212 (212Pb), a rare alpha-emitting radioisotope and one of the most potent therapeutic payloads against cancer cells.
People also ask
What is Orano Med?
Is Orano Med launching a 'alpha therapy laboratory' in Onnaing?
Who is Orano federal services?
Who is Roche & Orano Med?
Nuclear Medicine against cancer Orano is at the forefront of research in nuclear medicine and is developing new radioisotopic therapies against cancer. In 2014, Orano Med established a Lead-212 production facility in Plano, Texas. Uranium Sales & Services Orano offers an array of customizable services spanning the entire uranium life cycle.
Feb 2, 2024 · Orano Med, a subsidiary of the Orano Group, is a clinical-stage biotechnology company developing a new generation of targeted therapies against cancer using the unique properties of lead-212 (212 ...
Orano Med, based in Texas, is developing cancer-fighting isotopes for radioimmunotherapy, with research progressing for the next phase of FDA approval.
Orano Med Biotechnology Research Plano, TX 5,423 followers Innovative targeted alpha therapy to fight cancer using lead-212 (Pb-212) See jobs Follow View all 120 employees About us Based on an...